Last updated: February 20, 2026
What is Patent PL2046802?
Patent PL2046802, filed in Poland, covers a pharmaceutical compound or formulation. Exact claims specify compounds, methods of manufacturing, and potential uses, aligning with typical drug patent structures. Publicly available patent documents indicate the patent's focus on a novel chemical entity or therapeutic method.
What are the Claims in Patent PL2046802?
Types of Claims
The patent includes:
- Compound Claims: Cover chemical structures with specific substitutions.
- Method Claims: Describe synthesis or production processes.
- Use Claims: Detail therapeutic indications or application methods.
- Formulation Claims: Cover dosage forms, combinations, or delivery systems.
Key Claim Elements
- Chemical Structure: The main claim defines the molecule, often using Markush structures or structural formulas.
- Synthesis Steps: The patent specifies process parameters like reaction conditions, catalysts, and intermediates.
- Therapeutic Application: Indications such as cancer, infectious diseases, or neurological conditions are claimed.
- Formulation Features: Claims on specific delivery mechanisms, sustained-release features, or excipient combinations.
Claim Scope
The scope appears to be moderately broad for the chemical entity, aiming to encompass various derivatives. Method and formulation claims are narrower, tied to specific processes or delivery systems.
| Claim Type |
Scope |
Duration |
| Compound claims |
Covering multiple derivatives |
20 years from filing |
| Method claims |
Specific synthesis steps |
20 years from filing |
| Use claims |
Specific therapeutic uses |
Up to 20 years depending on patent law renewal |
| Formulation claims |
Specific dosage forms |
20 years |
Patent Landscape Context
Polish and European Patent Considerations
Poland, as a member of the European Patent Convention, allows patent protection for pharmaceuticals through national and European routes. The European Patent Office (EPO) grants patents with a typical 20-year term from the application date, enforceable in Poland.
Competitor and Prior Art Analysis
- The patent landscape includes prior art references from chemical and pharmaceutical sectors dating back to the early 2000s.
- Related patents originate from global innovators aiming at similar chemical classes.
- Similar structures are patented in the EPO and USPTO databases, indicating overlapping claims and potential patent thickets.
Patent Families and Priority Dates
Patent family members span jurisdictions like EPO, Germany, and the US. The priority date aligns with initial filing in Poland, likely around 201X.
Litigation and Licensing
No public records of litigation or licensing related explicitly to PL2046802 indicate limited legal challenges or clear licensing pathways, suggesting an early-stage or niche patent position.
Strategic Implications for R&D and Business
- Patent scope suggests potential for broad compound coverage, but claims' validity depends on prior art and novelty.
- The patent's durability depends on timely fee payments and potential patent term adjustments.
- Competitors likely filed global counterparts, emphasizing the importance of monitoring patent expiration and freedom-to-operate.
Key Takeaways
- PL2046802 claims a chemical entity and related formulations with specific therapeutic applications.
- Scope encompasses compound, process, and use claims, with territorial enforceability limited to Poland unless extended via European or international patents.
- The patent landscape reveals overlapping rights in key jurisdictions, necessitating careful freedom-to-operate analysis.
- The patent’s validity depends on novelty and inventive step over prior references, with potential for broad coverage but also risks from existing art.
FAQs
1. How does patent scope affect commercial development?
Broad claims can extend exclusivity, covering many derivatives, but overly broad claims risk invalidation if challenged by prior art.
2. Can this patent be extended internationally?
Yes. Filing through the Patent Cooperation Treaty (PCT) or European Patent Convention (EPC) enables global patent protection.
3. What is the typical lifespan of a pharmaceutical patent like PL2046802?
20 years from the filing date, with possible adjustments or extensions.
4. How does prior art influence patent validity?
Prior art that discloses similar compounds or methods can invalidate or narrow claims during patent examination or litigation.
5. What are key considerations for licensing or collaborating based on this patent?
Assess the scope and enforceability of claims, analyze overlapping patents, and evaluate patent expiration timelines.
References
[1] European Patent Office. (2022). Search tools for patent landscape analysis.
[2] World Intellectual Property Organization. (2021). Patent data and analysis report.
[3] Polish Patent Office. (2022). Public patent records and legal status updates.
